Central Coast Anticipates Increased VC, IPO, and M&A Activity in 2024by Terry Bingman 09.01.2024Analysis: Global Venture Capital Movement in 2023 reveals a slowdown in VC activity, but the Central Coast shows potential for ...
Midas List 2024: The Latest Ranking of Top VCs Now Accepting Submissionsby Mark Eisenberg 08.01.2024Submit your nominations now for the Forbes Midas List, the prestigious ranking of the world's top venture capitalists in private ...
Venture Capital Boosts Women’s Health Startupsby Mark Eisenberg 08.01.2024Investment in women's health startups has soared 314%, outpacing the overall health sector, according to a report from Silicon Valley ...
San Francisco Welcomes JPM24 with ADCs in High Demandby John Darbie 08.01.2024Licensing deals and ADCs drive biopharma deal flow in 2023, offering hope to an industry grappling with challenges. Big Pharma's ...
Papa John’s Dominates Mobile Order-Ahead App Marketby Lilu Anderson 06.01.2024In the latest Provider Ranking of Mobile Order-Ahead Apps, Papa John's Pizza maintains its No. 1 spot with 91 points, ...
The Urgent Need for Transparency in India’s VC Ecosystemby Mark Eisenberg 05.01.2024The dual nature of venture capital: Examining the LPs' perspective and their crucial role in minimizing risks and generating returns ...
Amer Sports’ IPO Proposal Revealed by Investing.comby Terry Bingman 04.01.2024Amer Sports, the global sports brand known for its craftsmanship and innovation, has filed for a proposed IPO. The company ...
“Firms to Watch: Navigating Turbulence with HumanForest and BrewDog”by Lilu Anderson 04.01.2024The rise of rental e-bikes is shaking up the transport industry in the UK, with HumanForest leading the way by ...
Alibaba’s Plunge: What Lies Ahead for the Former Wall Street Darling?by Mark Eisenberg 04.01.2024Alibaba has faced a challenging year of setbacks and struggles, from canceled IPOs to a record-breaking fine. The company's stock ...
CG Oncology Announces Anticipated IPO, Gaining Investor Interestby Mark Eisenberg 03.01.2024CG Oncology files for IPO, aims to revolutionize bladder cancer treatment with cretostimogene, a potential breakthrough therapy for high-risk bladder ...